influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) Injectable Suspension

influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension


influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) Injectable Suspension

influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension


octreotide 20 MG Delayed Release Oral Capsule

octreotide (as octreotide acetate) 20 MG Delayed Release Oral Capsule


emapalumab-lzsg 100 MG per 20 ML Injection

emapalumab-lzsg 100 MG in 20 ML Injection


influenza virus vaccine 2020-2021 (Hong Kong/Victoria/Victoria) 0.5 ML Prefilled Syringe

0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe


capsaicin 0.025 % / menthol 4 % Medicated Patch

capsaicin 0.00025 MG/MG / menthol 0.04 MG/MG Medicated Patch


cedazuridine 100 MG / decitabine 35 MG Oral Tablet


INQOVI 35 MG / 100 MG Oral Tablet
Inqovi 35 MG / 100 MG Oral Tablet

cedazuridine 100 MG / decitabine 35 MG Oral Tablet [Inqovi]


influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluarix Quadrivalent 2020-2021]


influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Flulaval Quadrivalent 2020-2021]


insulin lispro-aabc 100 UNT/ML [Lyumjev]


insulin lispro-aabc 200 UNT/ML [Lyumjev]


undecylenic acid 0.02 MG/MG / zinc undecylenate 0.2 MG/MG [Derman]


undecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML [Derman]


diphenhydrAMINE hydrochloride 20 MG/ML / levomenthol 10 MG/ML [Tact]

diphenhydramine hydrochloride 20 MG/ML / levomenthol 10 MG/ML [Tact]


diphenhydrAMINE hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG [Tact]

diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG [Tact]


influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020-2021]


influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Afluria Quadrivalent 2020-2021]


influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2020-2021]


influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML [Flublok Quadrivalent 2020-2021]


influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad 2020-2021]


influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad Quadrivalent 2020-2021]


hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML [Phesgo]


hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML [Phesgo]


influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2020-2021]


cedazuridine 100 MG / decitabine 35 MG [Inqovi]


diclofenac epolamine 0.013 MG/MG [Licart]


citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG [Phexxi]


insulin glargine Injectable Solution [Semglee]


methotrexate Prefilled Syringe [Reditrex]


ciclesonide Metered Dose Nasal Spray [Aservo]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2020-2021]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2020-2021]


insulin lispro Injectable Solution [Lyumjev]


diphenhydrAMINE / levomenthol Topical Cream [Tact]

diphenhydramine / levomenthol Topical Cream [Tact]


diphenhydrAMINE / levomenthol Topical Gel [Tact]

diphenhydramine / levomenthol Topical Gel [Tact]


fostemsavir Extended Release Oral Tablet [Rukobia]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2020-2021]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2020-2021]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2020-2021]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2020-2021]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2020-2021]


octreotide Delayed Release Oral Capsule [Mycapssa]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2020-2021]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2020-2021]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2020-2021]


chlorhexidine / miconazole Topical Spray [Malaseb]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2020-2021]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2020-2021]


hyaluronidase / pertuzumab / trastuzumab Injection [Phesgo]


benzethonium Topical Solution [New-Skin Liquid Bandage]


cedazuridine / decitabine Oral Tablet [Inqovi]


citric acid / lactate / potassium bitartrate Vaginal Gel [Phexxi]


Fluarix Quadrivalent 2020-2021 Injectable Product


Flulaval Quadrivalent 2020-2021 Injectable Product


Fluzone Quadrivalent 2020-2021 Injectable Product


Afluria Quadrivalent 2020-2021 Injectable Product


Flucelvax Quadrivalent 2020-2021 Injectable Product


Flublok Quadrivalent 2020-2021 Injectable Product


Fluad Quadrivalent 2020-2021 Injectable Product


influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML


influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML


influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML


influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML


influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML


influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML


influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML


influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML


influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML


influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML


influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML


influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML


influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML


influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML


acetaminophen / dextromethorphan / guaiFENesin Oral Capsule

acetaminophen / dextromethorphan / guaifenesin Oral Capsule


fostemsavir Extended Release Oral Tablet


ethanol / isopropyl alcohol Topical Spray


ethanol / isopropyl alcohol Medicated Pad


hyaluronidase / pertuzumab / trastuzumab Injection


ethanol / hydrogen peroxide Topical Spray


ethanol / isopropyl alcohol Topical Foam


citric acid / lactate / potassium bitartrate Vaginal Gel


benzalkonium / ethanol Medicated Pad or Tape


ethanol / isopropyl alcohol Medicated Pad or Tape


benzalkonium / ethanol / isopropyl alcohol Topical Product


hyaluronidase / pertuzumab / trastuzumab Injectable Product


ethanol / hydrogen peroxide Topical Product


citric acid / lactate / potassium bitartrate Vaginal Product


SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2

A formulation consisting of lipid nanoparticle (LNP) encapsulating a nucleoside modified messenger RNA (modRNA) encoding an optimized form of the full-length severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike glycoprotein (SP), with potential immunizing and anti-COVID-19 activities. Upon injection of tozinameran, the LNPs bind to the plasma membrane of nearby cells and release SARS-CoV-2 SP mRNA into the cell. The mRNA is then translated by the cellular protein translation machinery to produce SARS-CoV-2 SP. This may stimulate the immune system to induce an antibody and T-cell-mediated immune response. This may provide active immunization against SARS-CoV-2 infection. SP, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.


A preparation of autologous peripheral blood T-lymphocytes (PBTL) that have been transduced with a retroviral vector expressing a chimeric antigen receptor (CAR) consisting of an anti-CD19 single chain variable fragment (scFv) coupled to the costimulatory signaling domain CD28 and the zeta chain of the T-cell receptor (TCR)/CD3 complex (CD3 zeta), with potential immunostimulating and antineoplastic activities. Upon intravenous infusion and re-introduction of abrexucabtagene autoleucel into the patient, these cells bind to and induce selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen that is expressed in all B-cell lineage malignancies. CD3 zeta is one of several membrane-bound polypeptides found in the TCR/CD3 complex; it regulates both the assembly and cell surface expression of TCR complexes. CD28 is essential for CD4+ T-cell proliferation, interleukin-2 production, and T-helper type-2 (Th2) development. KTE-X19 has the same construct as axicabtagene ciloleucel, but differs in the manufacturing process in that KTE-X19 includes specific T-cell selection and lymphocyte enrichment necessary for activity against certain B-cell malignancies.


Bafiertam 95 MG Delayed Release Oral Capsule

monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam]


calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / K+ oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution [Xywav]

calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / Pot oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution [Xywav]

Xywav (calcium oxybate 0.234 GM / magnesium oxybate 0.096 GM / potassium oxybate 0.13 GM / sodium oxybate 0.04 GM) per 1 ML Oral Solution

calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / potassium oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution [Xywav]


MONJUVI 200 MG Injection
Monjuvi 200 MG Injection

tafasitamab-cxix 200 MG Injection [Monjuvi]


68 ML Tecartus 2940000 CELLS/ML Injection

Tecartus 200,000,000 CELLS in 68 ML Injection

Tecartus 200,000,000 CELLS per 68 ML Injection

68 ML brexucabtagene autoleucel 2940000 CELLS/ML Injection [Tecartus]


{25 (dexamethasone 1.5 MG Oral Tablet) } Pack [Zcort 7 Day Taper]


Blenrep 100 MG Injection
BLENREP 100 MG Injection

belantamab mafodotin-blmf 100 MG Injection [Blenrep]


Xeglyze 0.74 % Topical Lotion
Xeglyze 7.4 MG/ML Topical Lotion

Abametapir 7.4 MG/ML Topical Lotion [Xeglyze]


Evrysdi 60 MG per 80 ML Oral Solution
Evrysdi 0.75 MG/ML Oral Solution

Risdiplam 0.75 MG/ML Oral Solution [Evrysdi]


docosahexaenoic acid 200 MG / eicosapentaenoic acid 320 MG Oral Capsule


Upneeq 1 MG/ML Ophthalmic Solution
Upneeq 0.1 % Ophthalmic Solution

oxymetazoline hydrochloride 1 MG/ML Ophthalmic Solution [Upneeq]


1 ML Olinvyk 1 MG/ML (as oliceridine fumarate 1.3 MG /1 ML) Injection

1 ML Oliceridine 1 MG/ML Injection [Olinvyk]


cyclophosphamide 200 MG/ML Injectable Solution


influenza A virus A/Hawaii/66/2019 (H1N1) antigen


BREZTRI (budesonide 160 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT / glycopyrrolate 9 MCG/ACTUAT) Metered Dose Inhaler, 28 ACTUAT

BREZTRI 160/4.8/9 MCG/INHAL Metered Dose Inhaler, 28 Actuations

28 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler [Breztri]


BREZTRI 160/4.8/9 MCG/INHAL Metered Dose Inhaler, 120 Actuations

BREZTRI (budesonide 160 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT / glycopyrrolate 9 MCG/ACTUAT) Metered Dose Inhaler, 120 ACTUAT

120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler [Breztri]


pegfilgrastim-apgf 6 MG per 0.6 ML Prefilled Syringe

pegfilgrastim-apgf 6 MG in 0.6 ML Prefilled Syringe

0.6 ML pegfilgrastim-apgf 10 MG/ML Prefilled Syringe


Twirla 3 Count Weekly Transdermal System

{3 (168 HR ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR Transdermal System [Twirla]) } Pack [Twirla 3 Count Weekly Patch]


ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System

168 HR ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR Transdermal System


benzalkonium chloride 0.08 % Medicated Wipes

benzalkonium chloride 0.8 MG/ML Medicated Pad


isopropyl alcohol 0.74 ML/ML Topical Gel


Bravecto 100 MG Chewable Tablet
Bravecto 1-Month 100 MG Chewable Tablet

fluralaner 100 MG Chewable Tablet [Bravecto]


Bravecto 200 MG Chewable Tablet
Bravecto 1-Month 200 MG Chewable Tablet

fluralaner 200 MG Chewable Tablet [Bravecto]


Bravecto 1-Month 400 MG Chewable Tablet
Bravecto 400 MG Chewable Tablet

fluralaner 400 MG Chewable Tablet [Bravecto]


Bravecto 1-Month 45 MG Chewable Tablet
Bravecto 45 MG Chewable Tablet

fluralaner 45 MG Chewable Tablet [Bravecto]


Bravecto 1-Month 560 MG Chewable Tablet
Bravecto 560 MG Chewable Tablet

fluralaner 560 MG Chewable Tablet [Bravecto]


sodium hyaluronate 0.4 % Ophthalmic Ointment

sodium hyaluronate 0.004 MG/MG Ophthalmic Ointment


benzalkonium chloride 0.14 % Medicated Liquid Soap

benzalkonium chloride 1.4 MG/ML Medicated Liquid Soap


benzalkonium chloride 0.05 % Topical Solution

benzalkonium chloride 0.5 MG/ML Topical Solution


benzalkonium chloride 0.13 % / ethanol 4 % Medicated Pad

benzalkonium chloride 1.3 MG/ML / ethanol 0.04 ML/ML Medicated Pad


vancomycin 1.25 GM per 250 ML Injection
vancomycin 1.25 GM in 250 ML Injection
vancomycin 1250 MG per 250 ML Injection


vancomycin 1750 MG per 350 ML Injection
vancomycin 1.75 GM per 350 ML Injection
vancomycin 1.75 GM in 350 ML Injection


benzalkonium chloride 0.1 % / ethanol 80 % Medicated Pad

benzalkonium chloride 1 MG/ML / ethanol 0.8 ML/ML Medicated Pad


benzalkonium chloride 0.135 % Medicated Pad

benzalkonium chloride 0.135 % Medicated Wipe

benzalkonium chloride 1.35 MG/ML Medicated Pad


colloidal oatmeal 50 MG/ML Topical Lotion


NaCl 500 MG Oral Tablet
sodium chloride 500 MG Oral Tablet


isopropyl alcohol 0.71 ML/ML Topical Solution


5 ML Viltepso 50 MG/ML Injection
Viltepso 250 MG per 5 mL Injection
VILTEPSO 250 MG in 5 mL Injection

5 ML viltolarsen 50 MG/ML Injection [Viltepso]


doxylamine succinate 9.78 MG per 3 mL Oral Solution

doxylamine succinate 9.78 MG in 3 mL Oral Solution

doxylamine succinate 3.26 MG/ML Oral Solution


benzalkonium chloride 1.2 % Topical Solution

benzalkonium chloride 12 MG/ML Topical Solution


benzalkonium chloride 0.38 % Medicated Pad

benzalkonium chloride 3.8 MG/ML Medicated Pad


{2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack [Suprep Bowel Prep Kit]

{2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack [Suprep Pediatric Bowel Prep Kit]


KESIMPTA 20 MG per 0.4 ML Sensoready Pen Injector

0.4 ML ofatumumab 50 MG/ML Pen Injector [Kesimpta]


EPINEPHrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Topical Spray

EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Topical Spray

EPINEPHrine hydrochloride 0.1 MG/ML / lidocaine hydrochloride 50 MG/ML Topical Spray

epinephrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Topical Spray

epinephrine hydrochloride 0.1 MG/ML / lidocaine hydrochloride 50 MG/ML Topical Spray


camphor 10 % / menthol 12 % / methyl salicylate 15 % Topical Ointment

camphor 0.1 MG/MG / menthol 0.12 MG/MG / methyl salicylate 0.15 MG/MG Topical Ointment


dexbrompheniramine maleate 2 MG / phenylephrine HCl 7.5 MG Oral Tablet

dexbrompheniramine maleate 2 MG / phenylephrine hydrochloride 7.5 MG Oral Tablet


selamectin 120 MG/ML Topical Solution [Revolt]


selamectin 60 MG/ML Topical Solution [Revolt]


1 ML Enspryng 120 MG/ML Prefilled Syringe

Enspryng 120 MG per 1 ML Prefilled Syringe

Enspryng 120 MG in 1 ML Prefilled Syringe

1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng]


benzalkonium chloride 0.1 % / ethanol 4 % Medicated Pad

benzalkonium chloride 1 MG/ML / ethanol 0.04 ML/ML Medicated Pad


isopropyl alcohol 0.72 ML/ML Topical Solution


enrofloxacin 22.7 MG Oral Tablet [Enrosite]


enrofloxacin 68 MG Oral Tablet [Enrosite]


enrofloxacin 136 MG Oral Tablet [Enrosite]


2 ML Olinvyk 1 MG/ML (as oliceridine fumarate 1.3 MG /1 ML) Injection

2 ML Oliceridine 1 MG/ML Injection [Olinvyk]


Olinvyk 30 MG in 30 ML (For PCA Use Only) Injection

Olinvyk 30 MG per 30 ML (For PCA Use Only) Injection

30 ML Olinvyk 1 MG/ML (as oliceridine fumarate 1.3 MG / 1 ML) Injection

30 ML Oliceridine 1 MG/ML Injection [Olinvyk]


ethyl acetoacetate ethylene glycol ketal


triamcinolone acetonide 21-dipotassium phosphate


carbomer interpolymer type C (allyl sucrose crosslinked)


C8-10/propylene glycol/peg-22/decylene glycol ether


sodium 2-acrylamido-2-methyl-1-propane sulfonate/sodium acrylate/n-isopropylacrylamide/trimethyl(3-methacrylamidopropyl)ammonium chloride copolymer


brexucabtagene autoleucel 200,000,000 CELLS per 68 ML Injection

brexucabtagene autoleucel 200,000,000 CELLS in 68 ML Injection

68 ML brexucabtagene autoleucel 2940000 CELLS/ML Injection


influenza virus vaccine, 2020-2021 Quadrivalent Nasal Spray

influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray


calcium oxybate 0.234 GM / magnesium oxybate 0.096 GM / potassium oxybate 0.13 GM / sodium oxybate 0.04 GM per 1 ML Oral Solution

calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / Pot oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution

calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / K+ oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution

calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution

calcium/magnesium/potassium/sodium oxybates 0.5 GM per 1 ML Oral Solution

calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / potassium oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution


oxymetazoline hydrochloride 0.1 % Ophthalmic Solution

oxymetazoline hydrochloride 1 MG/ML Ophthalmic Solution


etanercept 25 MG in 0.5 ML Injection
etanercept 25 MG per 0.5 ML Injection


dexamethasone 1.5 MG Tablet 7 Day 25 Count Pack

{25 (dexamethasone 1.5 MG Oral Tablet) } Pack


1 daytime (6 OZ dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) / 1 nighttime (6 OZ acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack

1 daytime (6 OZ dextromethorphan HBr 20 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution) / 1 nighttime (6 OZ acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG per 20 ML Oral Solution) Pack

{1 (180 ML) (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / triprolidine hydrochloride 0.125 MG/ML Oral Solution) / 1 (180 ML) (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) } Pack

{1 (180 ML) (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / triprolidine hydrochloride 0.125 MG/ML Oral Solution) / 1 (180 ML) (dextromethorphan hydrobromide 1 MG/ML / guaiFENesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) } Pack

1 daytime (6 OZ dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution) / 1 nighttime (6 OZ acetaminophen 650 MG / dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG per 20 ML Oral Solution) Pack


{2 (355 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack

{2 (12 OZ magnesium sulfate 1.2 GM / potassium sulfate 2.35 GM / sodium sulfate 13.13 GM Oral Solution) } Pack


budesonide / formoterol / glycopyrronium


influenza A virus A/Hawaii/66/2019 (H1N1) antigen / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen


factor VIIa recombinant-jncw 5 MG Injection

coagulation factor VIIa (recombinant)-jncw 5 MG Injection


coagulation factor VIIa (recombinant)-jncw 1 MG Injection

factor VIIa recombinant-jncw 1 MG Injection


budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT 28 ACTUAT Metered Dose Inhaler

28 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler


budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT 120 ACTUAT Metered Dose Inhaler

120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler


belantamab mafodotin-blmf 100 MG Injection


viltolarsen 250 MG in 5 ML Injection
viltolarsen 250 MG per 5 ML Injection


Risdiplam 0.75 MG/ML Oral Solution
risdiplam 0.75 MG/ML Oral Solution
risdiplam 0.75 MG per ML Oral Solution


ofatumumab 20 MG per 0.4 ML Pen Injector


satralizumab-mwge 120 MG per 1 ML Prefilled Syringe

satralizumab-mwge 120 MG in 1 ML Prefilled Syringe

1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe


1 ML oliceridine 1 MG/ML (as oliceridine fumarate 1.3 MG /1 ML) Injection


2 ML oliceridine 1 MG/ML (as oliceridine fumarate 1.3 MG / 1 ML) Injection


oliceridine 30 MG per 30 ML (For PCA Use Only) Injection

oliceridine 30 MG in 30 ML (For PCA Use Only) Injection

30 ML oliceridine 1 MG/ML (as oliceridine fumarate 1.3 MG / 1 ML) Injection


coagulation factor VIIa (recombinant)-jncw 5 MG [Sevenfact]


coagulation factor VIIa (recombinant)-jncw 1 MG [Sevenfact]


budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT [Breztri]


brexucabtagene autoleucel 2940000 CELLS/ML [Tecartus]


belantamab mafodotin-blmf 100 MG [Blenrep]


axicabtagene ciloleucel 2940000 CELLS/ML [Yescarta]


influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML [Flumist Quadrivalent 2020-2021]


acetaminophen 500 MG / phenyltoloxamine citrate 30 MG [Dologesic]


acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Percogesic]


acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Contragesic]


oxymetazoline hydrochloride 1 MG/ML [Upneeq]


budesonide / formoterol / glycopyrronium Metered Dose Inhaler [Breztri]


brexucabtagene autoleucel Injection [Tecartus]


belantamab mafodotin Injection [Blenrep]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2020-2021]


bacitracin Ophthalmic Ointment [Baciguent]


satralizumab Prefilled Syringe [Enspryng]


oxymetazoline Ophthalmic Solution [Upneeq]


Flumist Quadrivalent 2020-2021 Nasal Product


Flumist Quadrivalent 2020-2021 Inhalant Product


coagulation factor VIIa (recombinant)-jncw 5 MG


coagulation factor VIIa (recombinant)-jncw 1 MG


brexucabtagene autoleucel 2940000 CELLS/ML


influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML


influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML


influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML


axicabtagene ciloleucel 2940000 CELLS/ML


budesonide / formoterol / glycopyrronium Metered Dose Inhaler


budesonide / formoterol / glycopyrronium Inhalant Product


brexucabtagene autoleucel Injectable Product


{3 (168 HR ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR Transdermal System) } Pack

ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System, 3 Count


EuCutaSol (crude coal tar 2 % (coal tar solution 10 % )) Topical Cream

coal tar 20 MG/ML Topical Cream [Eucutasol]


fentanyl 0.05 MG per 1 ML Prefilled Syringe

fentanyl (as fentanyl citrate) 0.05 MG per 1 ML Prefilled Syringe

fentaNYL (as fentaNYL citrate) 0.05 MG per 1 ML Prefilled Syringe

fentaNYL 0.05 MG in1 ML Prefilled Syringe

1 ML fentaNYL 0.05 MG/ML Prefilled Syringe

fentaNYL 0.05 MG per 1 ML Prefilled Syringe

1 ML fentanyl 0.05 MG/ML Prefilled Syringe


PANCREAZE 2,600 UNT / 15,200 UNT / 8,800 UNT Delayed Release Oral Capsule

Pancreaze (amylases 15,200 UNT / endopeptidases 8,800 UNT / lipase 2,600 UNT) Delayed Release Oral Capsule

amylase 15200 UNT / lipase 2600 UNT / protease 8800 UNT Delayed Release Oral Capsule [Pancreaze]


Lydexa 41.2 MG/ML Topical Cream
Lydexa 4.12 % Topical Cream

lidocaine hydrochloride 41.2 MG/ML Topical Cream [Lydexa]


{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 600 MG / 900 MG]

CABENUVA 600 MG / 900 MG Extended Release Kit


{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG]

CABENUVA 400 MG / 600 MG Extended Release Kit


efavirenz / emtricitabine / tenofovir disoproxil


bupivacaine hydrochloride 100 MG Drug Implant, 3 Implant Dose

{3 (bupivacaine hydrochloride 100 MG Drug Implant) } Pack

bupivacaine HCl 100 MG Drug Implant, 3 Implant Dose


{3 (bupivacaine hydrochloride 100 MG Drug Implant [Xaracoll]) } Pack [Xaracoll 3 Implant Dose]


{28 (norethindrone 0.35 MG Oral Tablet) } Pack [Lyleq 28 Day]


{1 (6 OZ) (acetaminophen 650 MG / dextromethorphan hydrobromide 20 MG / phenylephrine hydrochloride 10 MG / triprolidine hydrochloride 2.5 MG per 20 ML Oral Solution) / 1 (6 OZ) (acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine hydrochloride 10 MG per 20 ML Oral Solution)} Pack

{1 (6 OZ) (acetaminophen 650 MG / dextromethorphan hydrobromide 20 MG / phenylephrine hydrochloride 10 MG / triprolidine hydrochloride 2.5 MG per 20 ML Oral Solution) / 1 (6 OZ) (acetaminophen 650 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 20 ML Oral Solution)} Pack

1 nighttime (6 OZ acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) / 1 daytime (6 OZ acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution) Pack

{1 (180 ML) (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / phenylephrine hydrochloride 0.5 MG/ML / triprolidine hydrochloride 0.125 MG/ML Oral Solution) / 1 (180 ML) (acetaminophen 32.5 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) } Pack

{1 (180 ML) (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / phenylephrine hydrochloride 0.5 MG/ML / triprolidine hydrochloride 0.125 MG/ML Oral Solution) / 1 (180 ML) (acetaminophen 32.5 MG/ML / guaiFENesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) } Pack


{9 (Once-Daily gabapentin 300 MG Oral Tablet) / 24 (Once-Daily gabapentin 600 MG Oral Tablet) } Pack

gabapentin sample pack {9 (gabapentin 300 MG Once-Daily Oral Tablet) / 24 (gabapentin 600 MG Once-Daily Oral Tablet) }

gabapentin sample pack 300 MG (9), 600 MG (24) Once-Daily Oral Tablet


{9 (Once-Daily gabapentin 300 MG Oral Tablet [Gralise]) / 24 (Once-Daily gabapentin 600 MG Oral Tablet [Gralise]) } Pack [Gralise Sample Pack]


disintegrin and metalloproteinase domain-containing protein 11


3 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic]


cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit

{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack


{1 (11.1 ML casirivimab 120 MG/ML Injection) / 1 (11.1 ML imdevimab 120 MG/ML Injection) } Pack

casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 mL Injection, 1 vial (EUA)


REGEN-COV, 2-cartons (casirivimab 1, imdevimab 1) (EUA)

{1 (11.1 ML casirivimab 120 MG/ML Injection) / 1 (11.1 ML imdevimab 120 MG/ML Injection) } Pack [REGEN-COV 1/1]

REGEN-COV, 2-cartons (casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial) (EUA)


casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial (EUA)

{4 (2.5 ML casirivimab 120 MG/ML Injection) / 4 (2.5 ML imdevimab 120 MG/ML Injection) } Pack


REGEN-COV, 8-cartons (casirivimab 4, imdevimab 4) (EUA)

{4 (2.5 ML casirivimab 120 MG/ML Injection) / 4 (2.5 ML imdevimab 120 MG/ML Injection) } Pack [REGEN-COV 4/4]

REGEN-COV, 8-cartons (casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial) (EUA)


{1 (11.1 ML imdevimab 120 MG/ML Injection) / 4 (2.5 ML casirivimab 120 MG/ML Injection) } Pack

casirivimab 300 MG per 2.5 mL Injection, 1 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial (EUA)


REGEN-COV, 5-cartons (casirivimab 4, imdevimab 1) (EUA)

{1 (11.1 ML imdevimab 120 MG/ML Injection) / 4 (2.5 ML casirivimab 120 MG/ML Injection) } Pack [REGEN-COV 4/1]

REGEN-COV, 5-cartons (casirivimab 300 MG in 2.5 mL Injection, 4 vial / imdevimab 1332 MG in 11.1 MG Injection, 1 vial) (EUA)


casirivimab 1332 MG per 11.1 ML Injection, 1 vial / imdevimab 300 MG per 2.5 MG Injection, 4 vial (EUA)

casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial (EUA)

{1 (11.1 ML casirivimab 120 MG/ML Injection) / 4 (2.5 ML imdevimab 120 MG/ML Injection) } Pack


REGEN-COV, 5-cartons (casirivimab 1332 MG in 11.1 mL Injection, 1 vial / imdevimab 300 MG in 2.5 MG Injection, 4 vial) (EUA)

{1 (11.1 ML casirivimab 120 MG/ML Injection) / 4 (2.5 ML imdevimab 120 MG/ML Injection) } Pack [REGEN-COV 1/4]

REGEN-COV, 5-cartons (casirivimab 1, imdevimab 4) (EUA)


250 ML dexmedetomidine 0.004 MG/ML Injection [Precedex]


Retacrit 10000 UNT/ML Injectable Solution

epoetin alfa-epbx 10000 UNT/ML Injectable Solution [Retacrit]

EPO-epbx 10000 UNT/ML Injectable Solution [Retacrit]

Retacrit 10,000 UNT/ML Injectable Solution

Retacrit (epoetin alfa-epbx 20,000 UNT per 2 ML) Injectable Solution

ERYTHROPOIETIN-epbx 10000 UNT/ML Injectable Solution [Retacrit]


Pataday 0.7 % Ophthalmic Solution
Pataday 7 MG/ML Ophthalmic Solution

olopatadine 7 MG/ML Ophthalmic Solution [Pataday]


ethanol 63 % / isopropyl alcohol 7 % Topical Spray

ethanol 0.63 ML/ML / isopropyl alcohol 0.07 ML/ML Topical Spray


camphor 0.04 MG/MG / menthol 0.06 MG/MG Topical Gel


benzalkonium chloride 0.33 % / ethanol 80 % Medicated Pad

benzalkonium chloride 3.3 MG/ML / ethanol 0.8 ML/ML Medicated Pad


monomethyl fumarate Delayed Release Oral Capsule


monomethyl fumarate Delayed Release Oral Capsule [Bafiertam]


camphor 0.047 ML/ML / menthol 0.01 MG/MG Topical Gel


camphor 3 % / menthol 5 % Medicated Patch

camphor 0.03 MG / menthol 0.05 MG Medicated Patch


aspirin 6 MG/ML Oral Spray
ASA 6 MG/ML Oral Spray


calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate


calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / potassium oxybate 130 MG/ML / sodium oxybate 40 MG/ML [Xywav]


ethanol 73 % Medicated Pad
ethanol 73 % Medicated Wipes


camphor 0.5 % / menthol 1 % Topical Lotion

camphor 5 MG/ML / menthol 10 MG/ML Topical Lotion


aspirin 6 MG / menthol 5 MG Oral Lozenge


benzalkonium / ethanol / isopropyl alcohol Medicated Pad or Tape


benzalkonium / ethanol / isopropyl alcohol Medicated Pad


isopropyl alcohol 0.73 ML/ML Topical Gel


camphor 3.16 % / capsaicin 0.03 % Topical Ointment

camphor 0.0316 MG/MG / capsaicin 0.0003 MG/MG Topical Ointment


colloidal sulfur 1 % Medicated Liquid Soap

sulfur, colloidal 10 MG/ML Medicated Liquid Soap


camphor 5.9 % / menthol 0.8 % / methyl salicylate 4.6 % Medicated Patch

camphor 0.059 MG/MG / menthol 0.008 MG/MG / methyl salicylate 0.046 MG/MG Medicated Patch


GAVRETO 100 MG Oral Capsule
Gavreto 100 MG Oral Capsule

pralsetinib 100 MG Oral Capsule [Gavreto]


Cystadrops 3.7 MG/ML Ophthalmic Solution

Cystadrops 3.8 MG/ML Ophthalmic Solution

cysteamine 3.8 MG/ML Ophthalmic Solution [Cystadrops]


benzalkonium chloride 0.13 % Topical Ointment

benzalkonium chloride 0.0013 MG/MG Topical Ointment


Veklury 100 MG in 20 mL Injection
Veklury 100 MG per 20 ML Injection
20 ML Veklury 5 MG/ML Injection

20 ML remdesivir 5 MG/ML Injection [Veklury]


modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML per 0.5 MLInjection

MVA-BN 198000000 UNT/ML per 0.5 MLInjection

modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT in 1 mL Injection

modified Vaccinia Ankara-Bavarian Nordic 395000000 UNT per 1 ML Injection

0.5 ML modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML Injection


fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT

fluticasone furoate 200 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT

14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler


fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT [Trelegy]


Trelegy Ellipta (fluticasone furoate 200 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT) Dry Powder Inhaler, 14 ACTUAT

TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters

14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]


fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT

fluticasone furoate 200 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT

30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler


Trelegy Ellipta (fluticasone furoate 200 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT

TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters

30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]


dulaglutide 3 MG per 0.5 ML Auto-Injector

dulaglutide 3 MG in 0.5 ML Auto-Injector

0.5 ML dulaglutide 6 MG/ML Auto-Injector


0.5 ML Trulicity 6 MG/ML Auto-Injector
Trulicity 3 MG in 0.5 ML Auto-Injector
Trulicity 3 MG per 0.5 ML Auto-Injector

0.5 ML dulaglutide 6 MG/ML Auto-Injector [Trulicity]


dulaglutide 4.5 MG per 0.5 ML Auto-Injector

dulaglutide 4.5 MG in 0.5 ML Auto-Injector

0.5 ML dulaglutide 9 MG/ML Auto-Injector


Trulicity 4.5 MG per 0.5 ML Auto-Injector

Trulicity 4.5 MG in 0.5 ML Auto-Injector

0.5 ML dulaglutide 9 MG/ML Auto-Injector [Trulicity]


bupivacaine hydrochloride 100 MG Drug Implant


bupivacaine hydrochloride 100 MG [Xaracoll]


bupivacaine hydrochloride 100 MG Drug Implant [Xaracoll]


tramadol hydrochloride 5 MG per 1 ML Oral Solution

traMADol hydrochloride 5 MG in 1 ML Oral Solution

traMADol hydrochloride 5 MG per 1 ML Oral Solution

traMADol hydrochloride 5 MG/ML Oral Solution

tramadol hydrochloride 5 MG/ML Oral Solution


traMADol hydrochloride 5 MG/ML Oral Solution [Qdolo]

tramadol hydrochloride 5 MG/ML Oral Solution [Qdolo]


fluticasone propionate/salmeterol 113/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations

fluticasone propionate 113 MCG/ACTUAT / salmeterol 14 MCG/ACTUAT Dry Powder Inhaler with sensor, 60 ACTUATS

Sensor 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler


fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT [AirDuo]


AirDuo digihaler 113/14 Dry Powder Inhaler, 60 ACTUAT

AirDuo digihaler 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations

AirDuo digihaler 113/14 (fluticasone propionate 113 MCG / salmeterol 14 MCG (equivalent to salmeterol xinafoate 20.3 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT

Sensor 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo]


fluticasone propionate/salmeterol 55/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations

fluticasone propionate 55 MCG/ACTUAT / salmeterol xinafoate 14 MCG/ACTUAT Dry Powder Inhaler with sensor, 60 ACTUATS

Sensor 60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler


fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT [AirDuo]


AirDuo digihaler 55/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations

AirDuo digihaler 55/14 (fluticasone propionate 55 MCG / salmeterol 14 MCG (equivalent to salmeterol xinafoate 20.3 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT

AirDuo digihaler 55/14 Dry Powder Inhaler, 60 ACTUAT

Sensor 60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo]


fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations

fluticasone propionate 232 MCG / salmeterol 14 MCG (equivalent to salmeterol xinafoate 20.3 MCG) per ACTUAT Dry Powder Inhaler with sensor, 60 ACTUAT

Sensor 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler


fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT [AirDuo]


AirDuo digihaler 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations

AirDuo digihaler 232/14 (fluticasone propionate 232 MCG / salmeterol 14 MCG (equivalent to salmeterol xinafoate 20.3 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT

Sensor 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo]


fluticasone propionate 113 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations

Sensor 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT Dry Powder Inhaler


ArmonAir digihaler 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations

Sensor 60 ACTUAT Armonair 0.113 MG/ACTUAT Dry Powder Inhaler

Sensor 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT Dry Powder Inhaler [Armonair]


fluticasone propionate 232 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations

Sensor 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT Dry Powder Inhaler


ArmonAir digihaler 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations

Sensor 60 ACTUAT Armonair 0.232 MG/ACTUAT Dry Powder Inhaler

Sensor 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT Dry Powder Inhaler [Armonair]


fluticasone propionate 55 MCG/INHAL Dry Powder Inhaler with sensor, 60 Actuations

Sensor 60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT Dry Powder Inhaler


Sensor 60 ACTUAT Armonair 0.055 MG/ACTUAT Dry Powder Inhaler

ArmonAir digihaler 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations

Sensor 60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT Dry Powder Inhaler [Armonair]


petrolatum 77.99 % / zinc oxide 7.6 % Topical Ointment

petrolatum 0.78 MG/MG / ZNO 0.076 MG/MG Topical Ointment

petrolatum 0.78 MG/MG / zinc oxide 0.076 MG/MG Topical Ointment


ethinyl estradiol / levonorgestrel Topical Product


ethinyl estradiol / levonorgestrel Transdermal Product


ethinyl estradiol / levonorgestrel Transdermal System


ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR [Twirla]


ethinyl estradiol / levonorgestrel Transdermal System [Twirla]


Twirla Weekly Replacement Transdermal System

168 HR ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR Transdermal System [Twirla]


ePHEDrine sulfate 25 MG Oral Tablet [Bronkaid Max]

ephedrine sulfate 25 MG Oral Tablet [Bronkaid Max]


Onureg 200 MG Oral Tablet
azaCITIDine 200 MG Oral Tablet [Onureg]


Onureg 300 MG Oral Tablet
azaCITIDine 300 MG Oral Tablet [Onureg]


camphor 2 % / lidocaine 4 % / methyl salicylate 4 % Medicated Patch

camphor 0.02 MG/MG / lidocaine 0.04 MG/MG / methyl salicylate 0.04 MG/MG Medicated Patch


dexmedetomidine 1000 MG in 250 mL Injection

dexmedetomidine 0.004 MG/ML per 250 ML Injection

dexmedetomidine 1000 MG per 250 ML Injection

250 ML dexmedetomidine 0.004 MG/ML Injection


cysteamine 0.37 % (as cysteamine hydrochloride 0.55 % ) Ophthalmic Solution

cysteamine 3.8 MG/ML Ophthalmic Solution


cysteamine Ophthalmic Solution [Cystadrops]


Winlevi 1 % Topical Cream
Winlevi 10 MG/ML Topical Cream

Clascoterone 10 MG/ML Topical Cream [Winlevi]


colloidal oatmeal 1.5 % Medicated Liquid Soap

colloidal oatmeal 15 MG/ML Medicated Liquid Soap


lidocaine hydrochloride 20 MG/ML [Regenecare]


carprofen 100 MG Chewable Tablet [Carprovet]


carprofen 25 MG Chewable Tablet [Carprovet]


carprofen 75 MG Chewable Tablet [Carprovet]


5000 ML NaCl 5.03 MG/ML / sodium citrate 5.29 MG/ML Injection

citrate 18 mmol / sodium 140 mmol per L Injection (EUA)

citrate 18 mmol / sodium 140 mmol in L Injection (EUA)

5000 ML sodium chloride 5.03 MG/ML / sodium citrate 5.29 MG/ML Injection


sodium chloride 5.03 MG/ML / sodium citrate 5.29 MG/ML [Regiocit]


sodium chloride / sodium citrate Injectable Product


sodium chloride / sodium citrate Injection [Regiocit]


REGIOCIT (citrate 18 mmol / sodium 140 mmol in 1 L) 5000 ML Injection (EUA)

5000 ML NaCl 5.03 MG/ML / sodium citrate 5.29 MG/ML Injection [Regiocit]

Regiocit (citrate 18 mmol / sodium 140 mmol per L) 5000 ML Injection (EUA)

5000 ML sodium chloride 5.03 MG/ML / sodium citrate 5.29 MG/ML Injection [Regiocit]


sodium chloride / sodium citrate Injection


SARS-COV-2 (COVID-19) vaccine, vector - Ad26

A coronavirus vaccine composed of a genetically engineered, replication-incompetent, adenovirus serotype 26 (Ad26) vector expressing the stabilized pre-fusion spike (S) protein of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), with potential immunomodulating and anti-COVID-19 activities. Upon intramuscular administration of the COVID-19 vaccine Ad26.COV2.S, the Ad26 infects human cells, which produces SARS-CoV-2 S protein. The released S protein activates the immune system to induce a humoral and cell-mediated immune response against SARS-CoV-2. This may prevent SARS-CoV-2 infection and inhibit viral replication. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.


polatuzumab vedotin-piiq 30 MG Injection [Polivy]


melatonin 10 MG Soft Chew Gummy
melatonin 10 MG Chewable Tablet


melatonin 12 MG Disintegrating Oral Tablet


polatuzumab vedotin-piiq 30 MG Injection


ethanol 70 % / hydrogen peroxide 0.125 % Medicated Pad

ethanol 0.7 ML/ML / hydrogen peroxide 1.25 MG/ML Medicated Pad


camphor 5 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Ointment

camphor 0.05 MG/MG / Eucalyptus oil 0.012 MG/MG / menthol 0.026 MG/MG Topical Ointment


benzalkonium chloride 0.05 % / ethanol 65 % / isopropyl alcohol 10 % Medicated Pad

benzalkonium chloride 0.5 MG/ML / ethanol 0.65 ML/ML / isopropyl alcohol 0.1 ML/ML Medicated Pad


salicylic acid 0.1 MG/ML Topical Solution


ethanol 82.7 % Topical Solution
ethyl alcohol 82.7 % Topical Solution


benzalkonium chloride 0.1 % / ethanol 85 % Topical Spray

benzalkonium chloride 1 MG/ML / ethanol 0.85 ML/ML Topical Spray


benzalkonium chloride 0.121 % Medicated Wipe

benzalkonium chloride 0.121 % Topical Swab

benzalkonium chloride 1.21 MG/ML Medicated Pad


TRIPLICIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment

Triplicin (bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM) Ophthalmic Ointment

bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Triplicin]


benzalkonium chloride 0.1 % / lidocaine 5 % Medicated Liquid Soap

benzalkonium chloride 1 MG/ML / lidocaine 50 MG/ML Medicated Liquid Soap


ethanol 72.2 % Topical Gel
ethanol 72.16 % Topical Gel


Alkindi Sprinkle 0.5 MG Oral Granules
Alkindi 0.5 MG Oral Granules

hydrocortisone 0.5 MG Oral Granules [Alkindi]


Alkindi 1 MG Oral Granules
Alkindi Sprinkle 1 MG Oral Granules

hydrocortisone 1 MG Oral Granules [Alkindi]


Alkindi Sprinkle 2 MG Oral Granules
Alkindi 2 MG Oral Granules

hydrocortisone 2 MG Oral Granules [Alkindi]


Alkindi Sprinkle 5 MG Oral Granules
Alkindi 5 MG Oral Granules

hydrocortisone 5 MG Oral Granules [Alkindi]


Lyllana 0.025 MG/Day Twice Weekly Transdermal Patch

Lyllana 0.025 MG/Day Twice Weekly Transdermal System

84 HR Lyllana 0.00104 MG/HR Transdermal System

84 HR estradiol 0.00104 MG/HR Transdermal System [Lyllana]


Lyllana 0.0375 MG/Day Twice Weekly Transdermal Patch

Lyllana 0.0375 MG/Day Twice Weekly Transdermal System

84 HR Lyllana 0.00156 MG/HR Transdermal System

84 HR estradiol 0.00156 MG/HR Transdermal System [Lyllana]


Lyllana 0.05 MG/Day Twice Weekly Transdermal Patch

84 HR Lyllana 0.00208 MG/HR Transdermal System

Lyllana 0.05 MG/Day Twice Weekly Transdermal System

84 HR estradiol 0.00208 MG/HR Transdermal System [Lyllana]


Lyllana 0.075 MG/Day Twice Weekly Transdermal Patch

84 HR Lyllana 0.00313 MG/HR Transdermal System

Lyllana 0.075 MG/Day Twice Weekly Transdermal System

84 HR estradiol 0.00313 MG/HR Transdermal System [Lyllana]


Lyllana 0.1 MG/Day Twice Weekly Transdermal System

Lyllana 0.1 MG/Day Twice Weekly Transdermal Patch

84 HR Lyllana 0.00417 MG/HR Transdermal System

84 HR estradiol 0.00417 MG/HR Transdermal System [Lyllana]


Vasostrict 40 UNT per 100 ML Injection
100 ML Vasostrict 0.4 UNT/ML Injection
Vasostrict 40 UNT in 100 ML Injection

100 ML vasopressin (USP) 0.4 UNT/ML Injection [Vasostrict]


Vasostrict 60 UNT per 100 ML Injection
Vasostrict 60 UNT in 100 ML Injection
100 ML Vasostrict 0.6 UNT/ML Injection

100 ML vasopressin (USP) 0.6 UNT/ML Injection [Vasostrict]


povidone-iodine 1.25 % (titratable iodine 0.125 % ) Mucosal Spray

povidone-iodine 12.5 MG/ML Mucosal Spray


hydrocortisone 1 % / pramoxine HCl 0.5 % Topical Spray

hydrocortisone 10 MG/ML / pramoxine hydrochloride 5 MG/ML Topical Spray


chlorhexidine gluconate 0.2 % / ketoconazole 0.2 % Otic Solution

chlorhexidine gluconate 2 MG/ML / ketoconazole 2 MG/ML Otic Solution


SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 100 MCG/0.5 ML Injectable Suspension (EUA)

SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension


ULTOMIRIS 1100 MG in 11 ML Injection
Ultomiris 100 MG/ML per 11 ML Injection
Ultomiris 1100 MG per 11 ML Injection

11 ML ravulizumab-cwvz 100 MG/ML Injection [Ultomiris]


Ultomiris 300 MG per 3 ML Injection
ULTOMIRIS 300 MG in 3 ML Injection
Ultomiris 100 MG/ML per 3 ML Injection

3 ML ravulizumab-cwvz 100 MG/ML Injection [Ultomiris]


Inmazeb 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection

Inmazeb (atoltivimab-ebgn 241.7 MG / maftivimab-ebgn 241.7 MG / odesivimab-ebgn 241.7 MG) per 14.5 ML Injection

Inmazeb (atoltivimab-ebgn 16.67 MG/ML / maftivimab-ebgn 16.67 MG/ML / odesivimab-ebgn 16.67 MG/ML) per 14.5 ML Injection

Inmazeb 241.7 MG / 241.7 MG / 241.7 MG per 14.5 ML Injection

14.5 ML atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML Injection [Inmazeb]


alpha-succinimidyloxy carbonyl-omega-methoxy, polyoxyethylene MW 5000


N-alkyl dimethyl benzyl ammonium ion (C12-C18)


N-dialkyl methyl benzyl ammonium chloride (C12-C18)


3 ML semaglutide 1.34 MG/ML Pen Injector


vasopressin (USP) 40 UNT per 100 ML Injection

vasopressin (USP) 40 UNT in 100 ML Injection

100 ML vasopressin (USP) 0.4 UNT/ML Injection


vasopressin (USP) 60 UNT per 100 ML
vasopressin (USP) 60 UNT in 100 ML

100 ML vasopressin (USP) 0.6 UNT/ML Injection


ravulizumab-cwvz 100 MG/ML per 11 ML Injection

ravulizumab-cwvz 1100 MG per 11 ML Injection

ravulizumab-cwvz 1100 MG in 11 ML Injection

11 ML ravulizumab-cwvz 100 MG/ML Injection


ravulizumab-cwvz 300 MG in 3 ML Injection

ravulizumab-cwvz 100 MG/ML per 3 ML Injection

ravulizumab-cwvz 300 MG per 3 ML Injection

3 ML ravulizumab-cwvz 100 MG/ML Injection


atoltivimab-ebgn 241.7 MG / maftivimab-ebgn 241.7 MG / odesivimab-ebgn 241.7 MG per 14.5 ML Injection

atoltivimab-ebgn 16.67 MG/ML / maftivimab-ebgn 16.67 MG/ML / odesivimab-ebgn 16.67 MG/ML per 14.5 ML Injection

atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection

atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG per 14.5 ML Injection

14.5 ML atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML Injection


bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Triplicin]


vasopressin (USP) 0.4 UNT/ML [Vasostrict]


vasopressin (USP) 0.6 UNT/ML [Vasostrict]


atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML [Inmazeb]


bacitracin / neomycin / polymyxin B Ophthalmic Ointment [Triplicin]


atoltivimab / maftivimab / odesivimab Injection [Inmazeb]


ethanol / hydrogen peroxide Medicated Pad


chlorhexidine / ketoconazole Otic Solution


atoltivimab / maftivimab / odesivimab Injection


ethanol / hydrogen peroxide Medicated Pad or Tape


chlorhexidine / ketoconazole Otic Product


atoltivimab / maftivimab / odesivimab Injectable Product


An orally available inhibitor of human epidermal growth factor receptor (EGFR) exon 20 insertion mutations, with antineoplastic activity. Upon oral administration, mobocertinib, and its active metabolites, specifically and irreversibly binds to and inhibits exon 20 insertion mutations of EGFR. This prevents EGFR-mediated signaling and leads to cell death in tumor cells expressing exon 20 insertion mutations. In addition, mobocertinib may inhibit the activity of other EGFR family members, such as human epidermal growth factor receptor 2 (HER2; ERBB2) and HER4. EGFR, HER-2 and -4 are receptor tyrosine kinases often mutated in numerous tumor cell types. They play key roles in tumor cell proliferation and tumor vascularization.


An orally bioavailable inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2; ROCK-II), with potential immunomodulating activity. Upon oral administration, belumosudil binds to and inhibits the serine/threonine kinase activity of ROCK2. This inhibits ROCK2-mediated signal transduction pathways and modulates various pro- and anti-inflammatory immune cell responses through the regulation of signal transducer and activator of transcription 3 and 5 (STAT3/STAT5) phosphorylation. This downregulates pro-inflammatory Th17 cells and increases regulatory T (Treg) cells. Belumosudil also inhibits ROCK2-mediated fibrotic processes, including stress fiber formation, myofibroblast activation and pro-fibrotic gene transcription. ROCK2 is upregulated in various diseases, including various fibrotic, neurodegenerative and autoimmune diseases.


An orally active, small molecule inhibitor of hypoxia inducible factor (HIF)-2alpha (HIF-2a), with potential antineoplastic activity. Upon oral administration, belzutifan binds to and blocks the function of HIF-2alpha, thereby preventing HIF-2alpha heterodimerization and its subsequent binding to DNA. This results in decreased transcription and expression of HIF-2alpha downstream target genes, many of which regulate hypoxic signaling. This inhibits cell growth and survival of HIF-2alpha-expressing tumor cells. HIF-2alpha, the alpha subunit for the heterodimeric transcription factor HIF-2, is overexpressed in many cancers and promotes tumorigenesis.


An orally available inhibitor of the specific KRAS mutation, p.G12C, with potential antineoplastic activity. Upon oral administration, sotorasib selectively targets, binds to and inhibits the activity of the KRAS p.G12C mutant. This may inhibit growth in KRAS p.G12C-expressing tumor cells. The KRAS p.G12C mutation is seen in some tumor cell types and plays a key role in tumor cell proliferation.


A pegylated peptide inhibitor of human complement components C3 and C3b, with potential use as a treatment for various diseases in which excessive complement activation plays a key role, including paroxysmal nocturnal hemoglobinuria (PNH), geographic atrophy (GA), cold agglutinin disease (CAD), and C3 glomerulopathy (C3G). Upon administration, pegcetacoplan selectively binds to C3 and C3b and inhibits their activities. This prevents complement pathway activation, and inhibits complement-mediated inflammation and cell lysis. Excessive complement activation plays a key role in various inflammatory and autoimmune diseases, and leads to tissue destruction. C3 is a key component of the complement system, and the complement system is an integral component of the innate immune response.


The hydrochloride salt form of tepotinib, an orally bioavailable inhibitor of MET tyrosine kinase with potential antineoplastic activity. Upon oral administration, tepotinib selectively binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase. The receptor tyrosine kinase MET (also known as hepatocyte growth factor receptor or HGFR), is the product of the proto-oncogene c-Met and is overexpressed or mutated in many tumor cell types; this protein plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis.


The mesylate salt form of belumosudil, an orally bioavailable inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2; ROCK-II), with potential immunomodulating activity. Upon oral administration, belumosudil binds to and inhibits the serine/threonine kinase activity of ROCK2. This inhibits ROCK2-mediated signal transduction pathways and modulates various pro- and anti-inflammatory immune cell responses through the regulation of signal transducer and activator of transcription 3 and 5 (STAT3/STAT5) phosphorylation. This downregulates pro-inflammatory Th17 cells and increases regulatory T (Treg) cells. Belumosudil also inhibits ROCK2-mediated fibrotic processes, including stress fiber formation, myofibroblast activation and pro-fibrotic gene transcription. ROCK2 is upregulated in various diseases, including various fibrotic, neurodegenerative and autoimmune diseases.


SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML


SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 30 MCG/0.3 ML Injectable Suspension

SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension


An Fc-modified neutralizing, recombinant, human monoclonal antibody directed against the spike (S) protein receptor binding domain (RBD) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against Coronavirus disease 2019 (COVID-19). Upon administration of etesevimab, this agent specifically targets and binds to the RBD of the SARS-CoV-2 S protein. This blocks viral attachment and entry into human host cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may also provide temporary protection against infection with SARS-CoV-2. S-protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.


A neutralizing immunoglobulin G1 (IgG1) monoclonal antibody directed against the spike protein (SP) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration of bamlanivimab, this agent specifically targets and binds to the SP, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.


Impeklo 0.05 % Topical Lotion
Impeklo 0.05 MG/ACTUAT Topical Lotion
Impeklo 0.5 MG/ML Topical Lotion

clobetasol propionate 0.5 MG/ML Topical Lotion [Impeklo]


ERYTHROPOIETIN-epbx 20000 UNT/ML Injectable Solution [Retacrit]

EPO-epbx 20000 UNT/ML Injectable Solution [Retacrit]

Retacrit 20000 UNT/ML Injectable Solution

Retacrit 20,000 UNT/ML Injectable Solution

epoetin alfa-epbx 20000 UNT/ML Injectable Solution [Retacrit]


{24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Capsule) / 4 (ferrous fumarate 75 MG Oral Capsule) } Pack [Gemmily 28 Day]


Alocane 4 % Topical Spray Gel
Alocane 40 MG/ML Topical Spray
Alocane 4 % Topical Spray

lidocaine hydrochloride 40 MG/ML Topical Spray [Alocane]


{21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Chewable Tablet) / 7 (inert ingredients 1 MG Chewable Tablet) } Pack [Tyblume 28 Day]


magnesium sulfate 225 MG / Pot chloride 188 MG / sodium sulfate 1479 MG Oral Tablet [Sutab]

Sutab 1.479 GM / 0.188 GM / 0.225 GM Oral Tablet

SUTAB 1.479 GM / 0.188 GM / 0.225 GM Oral Tablet

magnesium sulfate 225 MG / K+ chloride 188 MG / sodium sulfate 1479 MG Oral Tablet [Sutab]

magnesium sulfate 225 MG / potassium chloride 188 MG / sodium sulfate 1479 MG Oral Tablet [Sutab]


bamlanivimab 700 MG in 20 mL Injection (EUA)

bamlanivimab 700 MG per 20 ML Injection (EUA)


ERYTHROPOIETIN-epbx 20000 UNT/ML Injectable Solution

epoetin alfa-epbx 20,000 UNT/ML Injectable Solution

EPO-epbx 20000 UNT/ML Injectable Solution

epoetin alfa-epbx 20000 UNT/ML Injectable Solution


loteprednol etabonate 0.25 % Ophthalmic Suspension

loteprednol etabonate 2.5 MG/ML Ophthalmic Suspension


magnesium sulfate 0.225 GM / potassium chloride 0.188 GM / sodium sulfate 1.479 GM Oral Tablet

magnesium sulfate 225 MG / Pot chloride 188 MG / sodium sulfate 1479 MG Oral Tablet

magnesium sulfate 225 MG / K+ chloride 188 MG / sodium sulfate 1479 MG Oral Tablet

magnesium sulfate 225 MG / potassium chloride 188 MG / sodium sulfate 1479 MG Oral Tablet


camphor 10 % / menthol 15 % / methyl salicylate 48 % Topical Oil

camphor 100 MG/ML / menthol 150 MG/ML / methyl salicylate 480 MG/ML Topical Oil


Aquaphor Itch Relief 0.01 MG/MG Topical Ointment

Aquaphor Itch Relief 1 % Topical Ointment

hydrocortisone 0.01 MG/MG Topical Ointment [Aquaphor Itch Relief]


Eticovo 25 MG per 0.5 ML Prefilled Syringe

Eticovo 25 MG in 0.5 mL Prefilled Syringe

0.5 ML Eticovo 50 MG/ML Prefilled Syringe

0.5 ML etanercept-ykro 50 MG/ML Prefilled Syringe [Eticovo]


benzalkonium chloride 1.6 % Medicated Liquid Soap

benzalkonium chloride 16 MG/ML Medicated Liquid Soap


benzalkonium chloride 1.6 % Topical Spray

benzalkonium chloride 16 MG/ML Topical Spray


benzalkonium chloride 0.156 % Medicated Pad

benzalkonium chloride 1.56 MG/ML Medicated Pad


benzalkonium chloride 0.016 MG/MG Topical Gel


benzalkonium chloride 1.6 % Medicated Pad

benzalkonium chloride 16 MG/ML Medicated Pad


camphor 40 MG/ML / menthol 30 MG/ML Topical Spray


menthol 9 % / methyl salicylate 3 % Topical Cream

menthol 90 MG/ML / methyl salicylate 30 MG/ML Topical Cream


uniferon 200 MG per 1 ML Injectable Solution

iron-dextran complex 200 MG/ML Injectable Solution [Uniferon]


EYsuVIS 0.25 % Ophthalmic Suspension
Eysuvis 2.5 MG/ML Ophthalmic Suspension
Eysuvis 0.25 % Ophthalmic Suspension

loteprednol etabonate 2.5 MG/ML Ophthalmic Suspension [Eysuvis]


benzalkonium chloride 0.15 % Topical Cream

benzalkonium chloride 1.5 MG/ML Topical Cream


casirivimab 1332 MG per 11.1 ML Injection (EUA)

casirivimab 1332 MG in 11.1 ML Injection (EUA)


casirivimab 300 MG per 2.5 ML Injection (EUA)

casirivimab 300 MG in 2.5 ML Injection (EUA)


imdevimab 1332 MG per 11.1 MG Injection (EUA)

imdevimab 1332 MG in 11.1 MG Injection (EUA)


imdevimab 300 MG in 2.5 ML Injection (EUA)

imdevimab 300 MG per 2.5 ML Injection (EUA)


lidocaine hydrochloride 1.5 % Topical Lotion

lidocaine hydrochloride 15 MG/ML Topical Lotion


camphor 3.5 % / menthol 3.5 % Topical Solution

camphor 35 MG/ML / menthol 35 MG/ML Topical Solution


magnesium potassium aluminosilicate fluoride


A recombinant, human immunoglobulin G1 (IgG1) kappa monoclonal antibody directed against the spike protein (SP) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration, casirivimab specifically targets and binds to the receptor-binding domain (RBD) of SP, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.


A recombinant, human immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the spike protein (SP) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration, imdevimab specifically targets and binds to the receptor-binding domain (RBD) of SP, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.


L-theanine 200 MG Oral Capsule
theanine 200 MG Oral Capsule


SARS-CoV-2 (COVID-19) vaccine, mRNA-1273

A vaccine consisting of a lipid nanoparticle (LNP) encapsulating a messenger RNA (mRNA) encoding the full-length, prefusion stabilized spike (S) protein of SARS-CoV-2, with potential immunizing activity against SARS-CoV-2. Upon administration of elasomeran, the lipid nanoparticle binds to the plasma membrane of cells and releases the mRNA into the cells. The mRNA is then translated by ribosomes to produce the SARS-CoV-2 S protein. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection.


magnesium sulfate / potassium chloride / sodium sulfate


epoetin alfa-epbx 10,000 UNT/ML Injectable Solution

epoetin alfa-epbx 20,000 UNT per 2 ML Injectable Solution

ERYTHROPOIETIN-epbx 10000 UNT/ML Injectable Solution

EPO-epbx 10000 UNT/ML Injectable Solution

epoetin alfa-epbx 10000 UNT/ML Injectable Solution


clobetasol propionate 0.5 MG/ML [Impeklo]


hydrocortisone 0.01 MG/MG [Aquaphor Itch Relief]


epoetin alfa-epbx 20000 UNT/ML [Retacrit]


iron-dextran complex 200 MG/ML [Uniferon]


modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML [Jynneos]


loteprednol etabonate 2.5 MG/ML [Eysuvis]


magnesium sulfate 225 MG / potassium chloride 188 MG / sodium sulfate 1479 MG [Sutab]


hydrocortisone Topical Ointment [Aquaphor Itch Relief]


epoetin alfa Injectable Solution [Retacrit]


loteprednol etabonate Ophthalmic Suspension [Eysuvis]


magnesium sulfate / potassium chloride / sodium sulfate Oral Tablet [Sutab]


iron-dextran complex (iron 200 MG/ML) Injectable solution

iron dextran 200 MG per 1 ML Injectable Solution

iron-dextran complex 200 MG/ML Injectable Solution


modified Vaccinia Ankara-Bavarian Nordic 198000000 UNT/ML


benzocaine / lidocaine / tetracaine Topical Spray


magnesium sulfate Granules for Oral Solution


magnesium sulfate / potassium chloride / sodium sulfate Oral Tablet


magnesium sulfate / potassium chloride / sodium sulfate Oral Product


magnesium sulfate / potassium chloride / sodium sulfate Pill


24 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 16 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

{16 (acetaminophen 325 MG / diphenhydrAMINE hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 24 (dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack

24 daytime (dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 16 nighttime (acetaminophen 325 MG / diphenhydramine HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

{16 (acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 24 (dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


amisulpride 2.5 MG/ML per 4 ML Injection


Barhemsys 2.5 MG/ML per 4 ML Injection
Barhemsys 10 MG per 4 ML Injection
4 ML Barhemsys 2.5 MG/ML Injection
Barhemsys 10 MG in 4 ML Injection

4 ML amisulpride 2.5 MG/ML Injection [Barhemsys]


lumasiran 94.5 MG (as lumasiran sodium 100 MG) per 0.5 ML Injection


Oxlumo 94.5 MG (as lumasiran sodium 100 MG) per 0.5 ML Injection

0.5 ML lumasiran 189 MG/ML Injection [Oxlumo]


salicylic acid 30 MG/ML [Nizoral Psoriasis]


salicylic acid Medicated Shampoo [Nizoral Psoriasis]


Nizoral Psoriasis 30 MG/ML Medicated Shampoo

salicylic acid 30 MG/ML Medicated Shampoo [Nizoral Psoriasis]


baloxavir marboxil Granules for Oral Suspension


baloxavir marboxil 40 MG Granules for Oral Suspension


baloxavir marboxil Granules for Oral Suspension [Xofluza]


Xofluza 40 MG Granules for Oral Suspension

baloxavir marboxil 40 MG Granules for Oral Suspension [Xofluza]


capromorelin 20 MG/ML Oral Solution [Elura]


orladeyo 150 MG Oral Capsule
Orladeyo 150 MG Oral Capsule

berotralstat 150 MG Oral Capsule [Orladeyo]


Orladeyo 110 MG Oral Capsule
orladeyo 110 MG Oral Capsule

berotralstat 110 MG Oral Capsule [Orladeyo]


Jock-Eze 10 MG/ML Topical Cream
Jock-Eze 1 % Topical Cream
JOCK-EZE 1 % Topical Cream

clotrimazole 10 MG/ML Topical Cream [Jock-Eze]


DANYELZA 40 MG in 10 ML Injection
10 ML Danyelza 4 MG/ML Injection
Danyelza 40 MG per 10 ML Injection

10 ML naxitamab-gqgk 4 MG/ML Injection [Danyelza]


naxitamab-gqgk 40 MG per 10 ML Injection


chlorhexidine gluconate 2 % Topical Spray

chlorhexidine gluconate 20 MG/ML Topical Spray


imidacloprid 100 MG/ML / moxidectin 25 MG/ML [Imoxi]


imidacloprid / moxidectin Topical Solution [Imoxi]


Imoxi (imidacloprid 10 % / moxidectin 2.5 % ) Topical Solution

imidacloprid 100 MG/ML / moxidectin 25 MG/ML Topical Solution [Imoxi]


{21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nymyo 28 Day]


SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein


SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Product


SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension


acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe


DTap-IPV-Hib-HepB 0.5 ML Prefilled Syringe

DTap-IPV-Hib-HepB (generic for Vaxelis) 0.5 ML Prefilled Syringe

0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe


acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Vaxelis]


Vaxelis (Diphtheria and Tetanus Toxoids and Acelluar Pertussis Absorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine) 0.5 ML Prefilled Syringe

0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Vaxelis]


Hetlioz 4 MG/ML Oral Suspension
Hetlioz LQ 4 MG/ML Oral Suspension

tasimelteon 4 MG/ML Oral Suspension [Hetlioz]


salicylic acid 0.015 MG/MG [Super Spot Remover]


Super Spot Remover 0.015 MG/MG Topical Gel

salicylic acid 0.015 MG/MG Topical Gel [Super Spot Remover]


pegfilgrastim Prefilled Syringe [Nyvepria]


Nyvepria 6 MG in 0.6 ML Prefilled Syringe

0.6 ML Nyvepria 10 MG/ML Prefilled Syringe

Nyvepria 6 MG per 0.6 ML Prefilled Syringe

0.6 ML pegfilgrastim-apgf 10 MG/ML Prefilled Syringe [Nyvepria]


setmelanotide 10 MG/ML (as setmelanotide acetate) Injectable Solution

setmelanotide 10 MG/ML Injectable Solution


setmelanotide Injectable Solution [Imcivree]


Imcivree 10 MG/ML (as setmelanotide acetate) Injectable Solution

setmelanotide 10 MG/ML Injectable Solution [Imcivree]


polyethylenimine hydrochloride (20000 MW)


zinc acetate 25 MG Oral Capsule [Wilzin]


ethanol 74.8 % / benzalkonium chloride 0.1 % Topical Solution

benzalkonium chloride 1 MG/ML / ethanol 0.748 ML/ML Topical Solution


SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML


cycloSPORINE, modified 100 MG/ML [Cyclavance]

cyclosporine, modified 100 MG/ML [Cyclavance]


cycloSPORINE, modified 100 MG/ML Oral Solution [Cyclavance]

cyclosporine, modified 100 MG/ML Oral Solution [Cyclavance]


dimethicone/peg-10/15 crosspolymer in dimethicone 6 (130000 cps)


benzalkonium chloride 0.05 % Medicated Liquid Soap

benzalkonium chloride 0.5 MG/ML Medicated Liquid Soap


imidacloprid 100 MG/ML / moxidectin 10 MG/ML [Imoxi]


Imoxi (imidacloprid 10 % / moxidectin 1 % ) Topical Solution

imidacloprid 100 MG/ML / moxidectin 10 MG/ML Topical Solution [Imoxi]


hydrogen peroxide 0.0214 MG/MG Toothpaste


camphor 5 % / methyl salicylate 50 % Topical Oil

camphor 50 MG/ML / methyl salicylate 500 MG/ML Topical Oil


chloroxylenol 1 % / miconazole nitrate 2 % / salicylic acid 2 % Medicated Shampoo

chloroxylenol 10 MG/ML / miconazole nitrate 20 MG/ML / salicylic acid 20 MG/ML Medicated Shampoo


bovine type II collagen (tracheal cartilage)


surfactant protein-D homotrimer, recombinant fragment human


An ointment containing an inhibitor for both Src tyrosine kinase and tubulin polymerization, with potential antineoplastic activity. Unlike other Src kinase inhibitors which bind to the ATP-binding site, tirbanibulin binds to the peptide substrate binding site of Src kinase, upon topical application. This inhibits both downstream signaling and the proliferation of tumor cells overexpressing Src. Src tyrosine kinase, a non-receptor tyrosine kinase upregulated in many tumor cell types, plays an important role in tumor cell proliferation, motility, invasiveness and survival. Tirbanibulin also binds to tubulin heterodimers and inhibits microtubule polymerization, which disrupts microtubule formation and mitosis, leading to further inhibition of cell proliferation. In addition, Tirbanibulin inhibits T-cell migration.


tirbanibulin 0.01 MG/MG Topical Ointment


Klisyri 1 % Topical Ointment
Klisyri 0.01 MG/MG Topical Ointment

tirbanibulin 0.01 MG/MG Topical Ointment [Klisyri]


adapalene / benzoyl peroxide Medicated Pad or Tape


adapalene / benzoyl peroxide Medicated Pad


adapalene 0.1 % / benzoyl peroxide 2.5 % Swab

adapalene 1 MG/ML / benzoyl peroxide 25 MG/ML Medicated Pad


A neutralizing human monoclonal antibody isolated from convalescent patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and directed against the spike (S) protein, that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration, cilgavimab specifically targets and binds to the SARS-CoV-2 S protein, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.


A neutralizing human monoclonal antibody isolated from convalescent patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and directed against the spike (S) protein, that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration, tixagevimab specifically targets and binds to the SARS-CoV-2 S protein, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.


{7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Nymyo 28 Day Pack]


Wynzora (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Cream

betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML Topical Cream [Wynzora]


Ebanga 400 MG Injection
ebanga 400 MG Injection

ansuvimab-zykl 400 MG Injection [Ebanga]


Gemtesa 75 MG Oral Tablet
GEMTESA 75 MG Once-Daily Oral Tablet


10 ML riTUXimab-arrx 10 MG/ML Injection [Riabni]

10 ML rituximab-arrx 10 MG/ML Injection [Riabni]


50 ML riTUXimab-arrx 10 MG/ML Injection [Riabni]

50 ML rituximab-arrx 10 MG/ML Injection [Riabni]


ORGOVYX 120 MG Oral Tablet
Orgovyx 120 MG Oral Tablet


Thyquidity 100 MCG in 5 mL Oral Solution

Thyquidity 100 MCG per 5 ML Oral Solution

levothyroxine sodium 0.02 MG/ML Oral Solution [Thyquidity]


Glyrx-PF 0.6 MG per 3 ML Prefilled Syringe

Glyrx-PF 0.6 MG in 3 mL Prefilled Syringe

3 ML glycopyrrolate 0.2 MG/ML Prefilled Syringe [Glyrx]


10 ML Margenza 25 MG/ML Injection
Margenza 250 MG per 10 ML Injection
Margenza 250 MG in 10 ML Injection

10 ML margetuximab-cmkb 25 MG/ML Injection [Margenza]


glucose 15000 MG Powder for Oral Solution


betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream

betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML Topical Cream


levothyroxine sodium 20 MCG per ML Oral Solution

levothyroxine sodium 100 MCG per 5 ML Oral Solution

levothyroxine sodium 100 MCG in 5 mL Oral Solution

levothyroxine sodium 0.02 MG/ML Oral Solution


{6 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 4 (acetaminophen 325 MG / diphenhydrAMINE hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack

6 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 4 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

6 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 4 nighttime (acetaminophen 325 MG / diphenhydramine HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

{6 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 4 (acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


12 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 8 nighttime (acetaminophen 325 MG / diphenhydramine HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

12 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 8 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

{12 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 8 (acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack

{12 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 8 (acetaminophen 325 MG / diphenhydrAMINE hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


sodium monofluorophosphate 0.72 % Toothpaste

sodium monofluorophosphate 0.0072 MG/MG Toothpaste


BZP hydrochloride 2.5 MG / spironolactone 20 MG Chewable Tablet [Cardalis]

benazepril hydrochloride 2.5 MG / spironolactone 20 MG Chewable Tablet [Cardalis]


BZP hydrochloride 5 MG / spironolactone 40 MG Chewable Tablet [Cardalis]

benazepril hydrochloride 5 MG / spironolactone 40 MG Chewable Tablet [Cardalis]


BZP hydrochloride 10 MG / spironolactone 80 MG Chewable Tablet [Cardalis]

benazepril hydrochloride 10 MG / spironolactone 80 MG Chewable Tablet [Cardalis]


iron-dextran complex 200 MG/ML Injectable Solution [Gleptosil]


Ursoferran 200 MG/ML Injectable Solution

iron-dextran complex 200 MG/ML Injectable Solution [Ursoferran]


lidocaine hydrochloride 4 % / menthol 1 % Topical Ointment

lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Ointment


{28 (ethinyl estradiol 0.02 MG / levonorgestrel 0.09 MG Oral Tablet) } Pack [Dolishale 28 Day]


cholecalciferol 0.625 MG/ML Oral Solution

cholecalciferol 25 MCG in 0.04 ML Oral Solution


diphenhydrAMINE hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Cream [Wal-Dryl]

Wal-Dryl (diphenhydrAMINE hydrochloride 1 % / zinc acetate 0.1 % ) Topical Cream

Wal-Dryl (diphenhydramine hydrochloride 1 % / zinc acetate 0.1 % ) Topical Cream

diphenhydramine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Cream [Wal-Dryl]


carboxymethylcellulose 1.5 MG Medicated Patch


trastuzumab-qyyp 150 MG Injection [Trazimera]


Iclusig 10 MG Oral Tablet
PONATinib 10 MG Oral Tablet [Iclusig]


ISOtretinoin 30 MG Oral Capsule [Accutane]

isotretinoin 30 MG Oral Capsule [Accutane]


camphor 30 MG/ML / menthol 20 MG/ML Topical Spray


oxymetazoline hydrochloride 0.05 % Nasal Gel

oxymetazoline hydrochloride 0.0005 MG/MG Nasal Gel


fentanyl (as fentanyl citrate) 100 MCG per 2 ML Prefilled Syringe

fentaNYL 100 MCG per 2 ML Prefilled Syringe

fentaNYL (as fentaNYL citrate) 100 MCG per 2 ML Prefilled Syringe

2 ML fentaNYL 0.05 MG/ML Prefilled Syringe

fentaNYL 100 MCG in 2 ML Prefilled Syringe

fentanyl 100 MCG per 2 ML Prefilled Syringe

2 ML fentanyl 0.05 MG/ML Prefilled Syringe


APAP 250 MG / ASA 250 MG / caffeine 65 MG Effervescent Oral Tablet

acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Effervescent Oral Tablet


{24 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 16 (acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack

{24 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 16 (acetaminophen 325 MG / diphenhydrAMINE hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack

24 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 16 nighttime (acetaminophen 325 MG / diphenhydramine HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

24 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 16 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack


hydroxyethyl palmityl oxyhydroxypropyl palmitamide


ethanethioic acid, S-(1-((1E)-2-hydroxyethenyl)butyl) ester


margetuximab-cmkb 250 MG per 10 ML Injection

margetuximab-cmkb 250 MG in 10 ML Injection

10 ML margetuximab-cmkb 25 MG/ML Injection


riTUXimab-arrx 100 MG in 10 ML Injection

rituximab-arrx 100 MG per 10 ML Injection

riTUXimab-arrx 100 MG per 10 ML Injection


riTUXimab-arrx 500 MG per 50 ML Injection

riTUXimab-arrx 500 MG in 50 ML Injection

rituximab-arrx 500 MG per 50 ML Injection


PONATinib (as PONATinib hydrochloride) 10 MG Oral Tablet

ponatinib (as ponatinib hydrochloride) 10 MG Oral Tablet


glycopyrrolate 0.6 MG per 3 ML Prefilled Syringe

glycopyrrolate 0.6 MG in 3 mL Prefilled Syringe

3 ML glycopyrrolate 0.2 MG/ML Prefilled Syringe


betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML [Wynzora]


iron-dextran complex 200 MG/ML [Gleptosil]


iron-dextran complex 200 MG/ML [Ursoferran]


iodine 10 MG/ML [Dairyland Brand Controlled Iodine Teat Dip]


diphenhydrAMINE hydrochloride 10 MG/ML / zinc acetate 1 MG/ML [Wal-Dryl]

diphenhydramine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML [Wal-Dryl]


levothyroxine sodium 0.02 MG/ML [Thyquidity]


citric acid 1530 MG / simethicone 40 MG / sodium bicarbonate 2210 MG [E-Z-Gas II]


lidocaine hydrochloride 41.2 MG/ML [Lydexa]


betamethasone / calcipotriene Topical Cream [Wynzora]


iron-dextran complex Injectable Solution [Gleptosil]


iron-dextran complex Injectable Solution [Ursoferran]


levothyroxine Oral Solution [Thyquidity]


citric acid / simethicone / sodium bicarbonate Granules for Oral Solution [E-Z-Gas II]


oxymetazoline hydrochloride 0.0005 MG/MG


betamethasone / calcipotriene Topical Cream


citric acid / simethicone / sodium bicarbonate Granules for Oral Solution


acetaminophen / aspirin / caffeine Effervescent Oral Tablet


A combination of two monoclonal antibodies, casirivimab and imdevimab, directed against the spike protein (SP) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration, casirivimab and imdevimab specifically target and bind to non-overlapping regions of the receptor-binding domain (RBD) of SP, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. Binding to two distinct regions of the RBD of SP may decrease the potential for virus escape mutants that occur upon treatment with a single SARS-CoV-2 antibody, and may provide enhanced protection against loss of efficacy.


A neutralizing human monoclonal antibody directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration, sotrovimab specifically targets and binds to an epitope on the SARS-CoV-2 S protein that is shared with SARS-CoV-1, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.


Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe

Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.5 ML Prefilled Syringe

0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere]


Fluzone Quadrivalent 2021 Southern Hemisphere vaccine Injectable Suspension

influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere]


Evkeeza 1200 MG in 8 ML Injection
Evkeeza 1200 MG per 8 ML Injection
8 ML Evkeeza 150 MG/ML Injection

8 ML evinacumab-dgnb 150 MG/ML Injection [Evkeeza]


Evkeeza 345 MG per 2.3 ML Injection
Evkeeza 345 MG in 2.3 ML Injection

2.3 ML evinacumab-dgnb 150 MG/ML Injection [Evkeeza]


4 ML labetalol hydrochloride 5 MG/ML Injection


An orally bioavailable prodrug of EIDD-1931, the synthetic ribonucleoside derivative N4-hydroxycytidine and ribonucleoside analog, with potential antiviral activity against a variety of RNA viruses. Upon oral administration, molnupiravir, being a prodrug, is metabolized into its active form EIDD-1931 and converted into its triphosphate (TP) form. The TP form of EIDD-1931 is incorporated into RNA and inhibits the action of viral RNA-dependent RNA polymerase. This results in the termination of RNA transcription and decreases viral RNA production, and viral RNA replication.


SARS-COV-2 (COVID-19) vaccine, vector - Ad26 0.5 ML Injectable Suspension (EUA)

SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension


Vocabria 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet

cabotegravir 30 MG Oral Tablet [Vocabria]


voclosporin 7.9 MG Oral Capsule [Lupkynis]


mannitol 40 MG Inhalation Powder [Bronchitol]


Tepmetko 225 MG (equivalent to tepotinib HCl hydrate 250 MG) Oral Tablet


Alocane Max Strength (benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % ) Topical Spray

Alocane Max Strength 0.13 % / 4 % Topical Spray

benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 40 MG/ML Topical Spray [Alocane Max Strength]


Xeljanz 1 MG/ML Oral Solution
Xeljanz 1 MG/mL Oral Solution

tofacitinib 1 MG/ML Oral Solution [Xeljanz]


Ukoniq 200 MG (as umbralisib tosylate 260.2 MG) Oral Tablet


Sesquient 75 MG/ML (as phenytoin sodium equivalents 100 MG per 2 ML) Injection

2 ML fosphenytoin sodium 75 MG/ML Injection [Sesquient]


amylase 15200 UNT / lipase 2600 UNT / protease 8800 UNT Delayed Release Oral Capsule


Primatene with ePHEDrine 12.5 MG Oral Tablet

Primatene with ephedrine 12.5 MG Oral Tablet

ePHEDrine hydrochloride 12.5 MG Oral Tablet [Primatene with ePHEDrine]

ephedrine hydrochloride 12.5 MG Oral Tablet [Primatene with ephedrine]


pramoxine hydrochloride 0.005 MG/MG Topical Ointment


Lactobacillus sporogenes 400,000,000 UNT Chewable Tablet

Bacillus coagulans 400000000 UNT Chewable Tablet


Lactobacillus sporogenes 2,000,000,000 UNT Oral Capsule

Bacillus coagulans 2000000000 UNT Oral Capsule


glucosamine HCl 500 MG / hyaluronic acid 1.1 MG / dimethyl sulfone 500 MG Oral Tablet

glucosamine hydrochloride 500 MG / hyaluronic acid 1.1 MG / methylsulfonylmethane 500 MG Oral Tablet


ePHEDrine hydrochloride 12.5 MG Oral Tablet

ephedrine hydrochloride 12.5 MG Oral Tablet


tepotinib 225 MG (equivalent to tepotinib HCl hydrate 250 MG) Oral Tablet


carboxymethylcellulose sodium 0.5 % / glycerin 1 % Ophthalmic Solution

carboxymethylcellulose sodium 5 MG/ML / glycerin 10 MG/ML Ophthalmic Solution


isopropyl alcohol 0.8 ML/ML Topical Spray


camphor 1.7 % / petrolatum, white 45.3 % Topical Ointment

camphor 0.017 MG/MG / petrolatum 0.453 MG/MG Topical Ointment


norepinephrine bitartrate 4 MG in 250 ML Injection

norepinephrine (as bitartrate) 4 MG per 250 ML Injection

250 ML norepinephrine 0.016 MG/ML Injection


norepinephrine (as bitartrate) 8 MG per 250 ML Injection

norepinephrine bitartrate 8 MG in 250 ML Injection

250 ML norepinephrine 0.032 MG/ML Injection


benzalkonium chloride 1.3 MG/ML Topical Solution [Bactine Wound Wash]

Bactine Wound Wash 1.3 MG/ML Topical Solution

Bactine Wound Wash 0.13 % Topical Solution


cabotegravir 400 MG per 2 ML Injection
2 ML cabotegravir 200 MG/ML Injection

cabotegravir 400 MG in 2 ML Extended Release Injection


3 ML rilpivirine 300 MG/ML Injection
rilpivirine 900 MG per 3 ML Injection

rilpivirine 900 MG in 3 ML Extended Release Injection


lidocaine HCl 4 % / menthol 4 % Medicated Patch

lidocaine hydrochloride 0.04 MG/MG / menthol 0.04 MG/MG Medicated Patch


Kaopectate Reformulated Aug 2006 262 MG Chewable Tablet

Kaopectate 262 MG Chewable Tablet, Reformulated Aug 2006

bismuth subsalicylate 262 MG Chewable Tablet [Kaopectate Reformulated Aug 2006]


cetylpyridinium chloride 0.05 % Mucosal Spray

cetylpyridinium chloride 0.5 MG/ML Mucosal Spray


benzocaine 10 % / petrolatum 45.9 % Topical Cream

benzocaine 100 MG/ML / petrolatum 459 MG/ML Topical Cream


etesevimab 700 MG per 20 ML Injection (EUA)

etesevimab 700 MG in 20 ML Injection (EUA)


simethicone 500 MG Oral Capsule [Phazyme]


tulathromycin 100 MG/ML Injectable Solution [Macrosyn]


Breyanzi 70,000,000 CELLS/mL in 4.6 mL Injection

4.6 ML Breyanzi 70,000,000 CELLS/ML Injection

Breyanzi 70,000,000 CELLS/ML per 4.6 ML Injection

4.6 ML lisocabtagene maraleucel 70000000 CELLS/ML Injection [Breyanzi]


collagenase clostridium histolyticum-aaes 0.92 MG Injection [Qwo]


collagenase clostridium histolyticum-aaes 1.84 MG Injection [Qwo]


carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 2300 mpa.s at 1%)


influenza A virus A/Victoria/2570/2019 (H1N1) antigen


cabotegravir 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet


cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit

{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack


Fluzone Quadrivalent 2021 Southern Hemisphere


influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza A virus A/Victoria/2570/2019 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen


menthol 10 % Topical Stick
menthol 10 % Topical Ointment


collagenase clostridium histolyticum-aaes 0.92 MG Injection


collagenase clostridium histolyticum-aaes 1.84 MG Injection


evinacumab-dgnb 345 MG per 2.3 ML Injection

evinacumab-dgnb 345 MG in 2.3 ML Injection

2.3 ML evinacumab-dgnb 150 MG/ML Injection


evinacumab-dgnb 1200 MG in 8 ML Injection

evinacumab-dgnb 1200 MG per 8 ML Injection

8 ML evinacumab-dgnb 150 MG/ML Injection


influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) Injectable Suspension

influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension


influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.5 ML Prefilled Syringe

influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.5 mL Prefilled Syringe

0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe


lisocabtagene maraleucel 70,000,000 CELLS/mL in 4.6 mL Injection

lisocabtagene maraleucel 70,000,000 CELLS/ML per 4.6 ML Injection

4.6 ML lisocabtagene maraleucel 70000000 CELLS/ML Injection


benzalkonium chloride 1.3 MG/ML [Bactine Wound Wash]


collagenase clostridium histolyticum-aaes 0.92 MG [Qwo]


collagenase clostridium histolyticum-aaes 1.84 MG [Qwo]


fosphenytoin sodium 75 MG/ML [Sesquient]


benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 40 MG/ML [Alocane Max Strength]


amylase 15200 UNT / lipase 2600 UNT / protease 8800 UNT [Pancreaze]


influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2021 Southern Hemisphere]


lisocabtagene maraleucel 70000000 CELLS/ML [Breyanzi]


benzalkonium Topical Solution [Bactine Wound Wash]


collagenase Clostridium histolyticum Injection [Qwo]


bismuth subsalicylate Chewable Tablet [Kaopectate Reformulated Aug 2006]


benzalkonium / lidocaine Topical Spray [Alocane Max Strength]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere]


influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere]


tulathromycin Injectable Solution [Macrosyn]


lisocabtagene maraleucel Injection [Breyanzi]


Kaopectate Reformulated Aug 2006 Chewable Product


Fluzone Quadrivalent 2021 Southern Hemisphere Injectable Product


collagenase clostridium histolyticum-aaes 0.92 MG


collagenase clostridium histolyticum-aaes 1.84 MG


influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML


lisocabtagene maraleucel 70000000 CELLS/ML


lisocabtagene maraleucel Injectable Product


1 ML triamcinolone acetonide 40 MG/ML Injection [Kenalog]


melatonin 3 MG / vitamin B6 hydrochloride 10 MG Extended Release Oral Tablet

melatonin 3 MG / pyridoxine hydrochloride 10 MG Extended Release Oral Tablet

melatonin 3 MG / vit-B6 hydrochloride 10 MG Extended Release Oral Tablet


FLUoxetine 20 MG Oral Tablet (PMDD)
PMDD FLUoxetine 20 MG Oral Tablet


Fergon 225 MG (iron 27 MG) Oral Tablet
Fergon 225 MG Oral Tablet

ferrous gluconate 225 MG Oral Tablet [Fergon]


false ragweed pollen extract 10000 UNT/mL Injectable Suspension

Ambrosia acanthicarpa pollen extract 10,000 UNT/ML Injectable Suspension

false ragweed pollen extract 10000 UNT/ML Injectable Suspension


smooth brome pollen extract 10000 UNT/mL Injectable Suspension

Bromus inermis pollen extract 10,000 UNT/ML Injectable Suspension

smooth brome pollen extract 10000 UNT/ML Injectable Suspension


Lolium perenne pollen extract 10000 UNT/ML Injectable Suspension

perennial rye grass pollen extract 10000 UNT/mL Injectable Suspension

perennial rye grass pollen extract 10000 UNT/ML Injectable Suspension


redroot pigweed pollen extract 10000 UNT/mL Injectable Suspension

Amaranthus retroflexus pollen extract 10,000 UNT/ML Injectable Suspension

redroot pigweed pollen extract 10000 UNT/ML Injectable Suspension


Artemisia tridentata pollen extract 10,000 UNT/ML Injectable Suspension

common sagebrush pollen extract 10000 UNT/mL Injectable Suspension

common sagebrush pollen extract 10000 UNT/ML Injectable Suspension


Acer negundo pollen extract 10,000 UNT/ML Injectable Suspension

box elder maple pollen extract 10000 UNT/mL Injectable Suspension

box elder maple pollen extract 10000 UNT/ML Injectable Suspension


Populus deltoides subsp. monilifera pollen extract 10,000 UNT/ML Injectable Suspension

western cottonwood pollen extract 10,000 UNT/ML Injectable Suspension

plains cottonwood pollen extract 10000 UNT/mL Injectable Suspension

plains cottonwood pollen extract 10000 UNT/ML Injectable Suspension


Carya illinoinensis pollen extract 10,000 UNT/ML Injectable Suspension

pecan pollen extract 10000 UNT/mL Injectable Suspension

pecan pollen extract 10000 UNT/ML Injectable Suspension


Rumex crispus pollen extract 10,000 UNT/ML Injectable Suspension

yellow dock pollen extract 10000 UNT/mL Injectable Suspension

yellow dock pollen extract 10000 UNT/ML Injectable Suspension


sheep sorrel pollen extract 10,000 UNT/mL Injectable Suspension

Rumex acetosella pollen extract 10,000 UNT/ML Injectable Suspension

sheep sorrel pollen extract 10000 UNT/ML Injectable Suspension


FLUoxetine 10 MG Oral Tablet (PMDD)
PMDD fluoxetine 10 MG Oral Tablet


pegfilgrastim 10 MG/ML per 0.6 ML Injection


Neulasta Onpro 6 MG per 0.6 ML Injection

0.6 ML pegfilgrastim 10 MG/ML Injection [Neulasta]


short ragweed pollen extract 20000 UNT/mL Injectable Suspension

Ambrosia artemisiifolia pollen extract 20,000 UNT/ML Injectable Suspension

short ragweed pollen extract 20000 UNT/ML Injectable Suspension


giant ragweed pollen extract 20,000 UNT/mL Injectable Suspension

Ambrosia trifida pollen extract 20,000 UNT/ML Injectable Suspension

giant ragweed pollen extract 20000 UNT/ML Injectable Suspension